The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CADL | +7.46% | N/A | N/A | -34% |
| S&P | +12.57% | +87.93% | +13.44% | +53% |
Candel Therapeutics, Inc. is a late clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | $0.00M | 100.0% |
| Market Cap | $279.97M | 25.9% |
| Market Cap / Employee | $7.37M | 0.0% |
| Employees | 38 | -9.5% |
| Net Income | -$11.27M | -5.9% |
| EBITDA | -$10.94M | -31.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $86.96M | 425.2% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.04M | -87.3% |
| Short Term Debt | $7.30M | -29.5% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -39.54% | 106.3% |
| Return On Invested Capital | -75.13% | -11.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$8.92M | -43.8% |
| Operating Free Cash Flow | -$8.89M | -43.4% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -18.28 | 4.00 | 3.34 | 3.10 | -114.37% |
| Price to Tangible Book Value | -18.28 | 4.00 | 3.34 | 3.10 | -114.37% |
| Enterprise Value to EBITDA | -26.00 | -27.80 | -28.94 | -15.38 | -29.80% |
| Return on Equity | -139.6% | -98.1% | -55.2% | -70.2% | -94.78% |
| Total Debt | $16.02M | $13.47M | $10.91M | $8.34M | -55.06% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
